Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Hillyer

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
American Journal of Clinical Pathology|October 1, 1990
EDTA-dependent leukoagglutinationC D Hillyer, A N Knopf, E M Berkman
Transfusion|September 1, 1990
The risk of cytomegalovirus infection in solid organ and bone marrow transplant recipients: transfusion of blood productsC D Hillyer, D R Snydman, E M Berkman
Bone Marrow Transplantation|June 1, 1991
A commercially available culture medium compares favorably to laboratory medium (LM) for assay of peripheral blood colony forming units (CFU)C D Hillyer, K O Tiegerman, E M Berkman
Transfusion|May 1, 1991
Increase in circulating colony-forming units-granulocyte-macrophage during large-volume leukapheresis: evaluation of a new cell separatorC D Hillyer, K O Tiegerman, E M Berkman
Transfusion|November 1, 1990
Density gradient separation of peripheral blood stem cells: comparison of an automated cell processing device and manual methodsC D Hillyer, K O Tiegerman, E M Berkman
Transfusion|May 29, 2000
Longitudinal monitoring of WBC subsets in packed RBC units after filtration: implications for transfusion transmission of infectionsJ D Roback, R A Bray, C D Hillyer
Journal of Hematotherapy|August 1, 1995
The role of bone marrow transplantation in the treatment of myelodysplastic syndromesA B Schultz, R B Geller, C D Hillyer
Anesthesia and Analgesia|April 27, 2000
The in vitro effects of antithrombin III on the activated coagulation time in patients on heparin therapyJ H Levy, F Montes, F Szlam, et al.
Transfusion|May 26, 2004
Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A,B: implications for transfusion policyC D Josephson, N C Mullis, C Van Demark, et al.
Transfusion|October 1, 1994
Methods for the reduction of transfusion-transmitted cytomegalovirus infection: filtration versus the use of seronegative donor unitsC D Hillyer, R K Emmens, M Zago-Novaretti, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
American Journal of Clinical Pathology|October 1, 1990
EDTA-dependent leukoagglutinationC D Hillyer, A N Knopf, E M Berkman
Transfusion|September 1, 1990
The risk of cytomegalovirus infection in solid organ and bone marrow transplant recipients: transfusion of blood productsC D Hillyer, D R Snydman, E M Berkman
Bone Marrow Transplantation|June 1, 1991
A commercially available culture medium compares favorably to laboratory medium (LM) for assay of peripheral blood colony forming units (CFU)C D Hillyer, K O Tiegerman, E M Berkman
Transfusion|May 1, 1991
Increase in circulating colony-forming units-granulocyte-macrophage during large-volume leukapheresis: evaluation of a new cell separatorC D Hillyer, K O Tiegerman, E M Berkman
Transfusion|November 1, 1990
Density gradient separation of peripheral blood stem cells: comparison of an automated cell processing device and manual methodsC D Hillyer, K O Tiegerman, E M Berkman
Transfusion|May 29, 2000
Longitudinal monitoring of WBC subsets in packed RBC units after filtration: implications for transfusion transmission of infectionsJ D Roback, R A Bray, C D Hillyer
Journal of Hematotherapy|August 1, 1995
The role of bone marrow transplantation in the treatment of myelodysplastic syndromesA B Schultz, R B Geller, C D Hillyer
Anesthesia and Analgesia|April 27, 2000
The in vitro effects of antithrombin III on the activated coagulation time in patients on heparin therapyJ H Levy, F Montes, F Szlam, et al.
Transfusion|May 26, 2004
Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A,B: implications for transfusion policyC D Josephson, N C Mullis, C Van Demark, et al.
Transfusion|October 1, 1994
Methods for the reduction of transfusion-transmitted cytomegalovirus infection: filtration versus the use of seronegative donor unitsC D Hillyer, R K Emmens, M Zago-Novaretti, et al.
Pageof 6